Last reviewed · How we verify
magnesium-aluminium antacid gel
magnesium-aluminium antacid gel is a Small molecule drug developed by Chulalongkorn University. It is currently FDA-approved.
At a glance
| Generic name | magnesium-aluminium antacid gel |
|---|---|
| Sponsor | Chulalongkorn University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients (PHASE4)
- Alginate-based Reflux Suppressant and Magnesium-aluminium Antacid Gel for Treatment of Heartburn in Pregnancy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- magnesium-aluminium antacid gel CI brief — competitive landscape report
- magnesium-aluminium antacid gel updates RSS · CI watch RSS
- Chulalongkorn University portfolio CI
Frequently asked questions about magnesium-aluminium antacid gel
What is magnesium-aluminium antacid gel?
magnesium-aluminium antacid gel is a Small molecule drug developed by Chulalongkorn University.
Who makes magnesium-aluminium antacid gel?
magnesium-aluminium antacid gel is developed and marketed by Chulalongkorn University (see full Chulalongkorn University pipeline at /company/chulalongkorn-university).
What development phase is magnesium-aluminium antacid gel in?
magnesium-aluminium antacid gel is FDA-approved (marketed).